Rocket Pharmaceuticals IncEquity-NMS: RCKT
Equity-NMS: RCKT
$30.53
+1.23
(3 Mar)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$30.53
Open
$30.53
Today’s high
$31.24
Today’s low
$29.39
52W low
$14.89
52W high
$32.53
1Y
46.57%
5Y
11.81%
Shares O/S
90.50M
Market cap
2.76B
Insights
RCKT price is below its 200 day moving average
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About Rocket Pharmaceuticals Inc

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare disorders. The Company's clinical programs using lentiviral vector (LVV)-based gene therapy are for the treatment of Fanconi Anemia (FA), a genetic disease that leads to bone marrow failure and potentially cancer, Leukocyte Adhesion Deficiency-I (LAD-I), a severe paediatric genetic disorder that causes recurrent and life-threatening infections which are frequently fatal, and Pyruvate Kinase Deficiency (PKD), a rare, monogenic red blood cell disorder resulting in increased red cell destruction and mild to life-threatening anemia.

The Company's first clinical program using adeno-associated virus (AAV)-based gene therapy is for Danon Disease, a pediatric heart failure condition. It also has a preclinical AAV-based gene therapy program in PKP2-arrhythmogenic cardiomyopathy (ACM) and BAG3-associated dilated cardiomyopathy (DCM). .


FAQs

Can I buy Rocket Pharmaceuticals Inc shares in India?
How to buy Rocket Pharmaceuticals Inc shares in India?
What is the share price of Rocket Pharmaceuticals Inc?
What is the Market Capitalization of Rocket Pharmaceuticals Inc?
What is the PE ratio of Rocket Pharmaceuticals Inc?
Is Rocket Pharmaceuticals Inc a good stock to buy?
In which sector / industry does Rocket Pharmaceuticals Inc operate?